KBIO LABS Inc. (KOSDAQ:038530)
3,785.00
-175.00 (-4.42%)
At close: Oct 2, 2026
| Market Cap | 19.56B -32.5% |
| Revenue (ttm) | 92.08B +57.6% |
| Net Income | -14.88B |
| EPS | -3,228.87 |
| Shares Out | 5.17M |
| PE Ratio | 0.75 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 8,300 |
| Open | 4,355.00 |
| Previous Close | 3,960.00 |
| Day's Range | 3,785.00 - 4,355.00 |
| 52-Week Range | 3,610.00 - 13,750.00 |
| Beta | 0.87 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |